Secukinumab Open Label Roll-over Extension Protocol
Clinical trial NCT04638647 · RECRUITING
Trial details
- NCT number
- NCT04638647
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-22
- Primary completion
- 2030-01-29
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.